| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 152,119 | 150,543 | 151,629 | 206,706 | | Cost of Revenue | 71,202 | 72,945 | 78,406 | 117,939 | | | Gross Profit | 80,917 | 77,598 | 73,223 | 88,767 | | | Operating Expenses | | Research Development | 29,262 | 30,661 | 31,051 | 33,291 | | Selling General and Administrative | 56,798 | 54,553 | 55,894 | 66,933 | | Non Recurring | 7,891 | 5,019 | 4,222 | 86,733 | | Others | 2,782 | 2,622 | 2,375 | 2,837 | | | | Total Operating Expenses | 96,733 | 92,855 | 93,542 | 189,794 | | | | Operating Income or Loss | (19,214) | (15,257) | (20,319) | (101,027) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,232) | 243 | 203 | 488 | | Earnings Before Interest And Taxes | (19,048) | (15,014) | (20,116) | (100,539) | | Interest Expense | 406 | 185 | 50 | 157 | | Income Before Tax | (19,454) | (15,199) | (20,166) | (100,696) | | Income Tax Expense | (2,246) | 750 | (2,889) | (443) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,208) | (15,949) | (17,277) | (100,253) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,208) | (15,949) | (17,277) | (100,253) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,208) | ($15,949) | ($17,277) | ($100,253) |
|
0.50% Nasdaq 0.00%
Income Statement
